Skip to content
India Japan Kaizen
← All stories
🩺

Big Names Circle Noida's Device Park, Still Not Japan's

November 15, 2026 · by India Japan Kaizen Team

India Japan Kaizen — Health & Beauty Bridge Series, Part 8

Part 7 closed with a missed deadline rather than a missing name at YEIDA's device park, plus two threads the series hadn't pulled before: Japan's own government quietly tightening the welcome mat for the same kind of medical travelers it's courting, and a second Japanese cosmetics giant, Shiseido, reportedly eyeing Indian manufacturing without yet committing to it. A week back at those threads found the deadline still unruled and Shiseido still just a rumor — but it also found the device park's list of interested companies growing far past one Indian device maker, Japan's insurance study finally picking up a named system and a date to attach itself to, and a beauty-clinic operator this series has tracked for three parts now pouring real money into exactly the kind of inbound-language investment this series keeps asking for — just not in the language that would actually open its doors to India.

A Bigger Guest List, Still No Japanese Name

Start again with the device park, because the guest list, if not the allotment list, has grown. Part 7 left TI Medical, an 11-acre Indian device maker, as the only name worth naming among the park's 101 allotted plots — a figure that covers just under half of the 203 industrial plots YEIDA has developed within its roughly 350-acre first phase, representing a reported ₹1,291 crore in committed investment so far. What's changed since isn't the allotment count; it's who's circling it. A Wipro GE Healthcare delegation visited the park in January 2026 and came away interested in roughly 10 acres, a request YEIDA says it's still reviewing under its standard allotment policy. Separately, state officials have told local press they're in talks with Philips and GE HealthCare's parent company about anchoring manufacturing at the site, and Panacea Medical Technologies has said it's considering a unit there too. None of that is a signed deal, and none of the three names is Japanese — which means Medical Excellence Japan's May 2026 framework agreement with YEIDA still hasn't produced a single named Japanese tenant, a year and a half after the two sides first met. The deadline question Part 7 flagged — YEIDA's request to push completion from March 2026 to March 2027 — also still has no public ruling from the Centre.

Japan's Insurance Study Gets a System and a Date

Japan's own insurance-before-entry question, which Part 7 could only describe as "under study," picked up something closer to a mechanism this year. On April 23, 2026, Justice Minister Keisuke Suzuki confirmed that Japan's planned electronic travel authorization system — provisionally named JESTA — is targeted for launch by the end of fiscal year 2028, applying to visa-exempt travelers from the roughly 70 countries and territories that can currently enter Japan for short stays without one. Several outlets now report that the mandatory travel-medical-insurance requirement Part 7 tracked is being discussed as a feature that could attach to JESTA itself, with at least one account floating a start as early as 2027 — though no ministry has confirmed that date, and the government's own language still calls the insurance piece a study, not a rule. One caveat worth flagging rather than skipping past: India isn't on Japan's visa-exemption list, so Indian travelers already apply for visas before entering Japan, and it isn't yet clear whether an eventual JESTA-linked insurance rule would govern Indian medical travelers through that separate visa process, alongside it, or not at all. Either way, the ¥10,000 unpaid-bill reporting threshold that took effect in April 2026 is already live and already counts against any visitor's record, Indian or otherwise.

Deeper Into Chinese, Still Not Into Hindi

On the consumer side, Parts 4 through 6 named SBC Medical, the operator behind Shonan Beauty Clinic, as the clearest example of a Japanese aesthetic-medicine chain investing seriously in inbound patients while routing all of that investment past India. That pattern held this year, but it sharpened. During 2026, SBC Medical rolled out Talk Bridge, a dedicated medical-aesthetics interpretation app, across its full Shonan Beauty Clinic network, and has said the service now handles on the order of 300 Chinese-language interpretation requests a month against a stated internal target above 800. Shonan Beauty Clinic was also named to Newsweek's World's Best Hospitals & Clinics for Medical Tourism list for 2027, reported in early November. Both are real signs the company is spending money and attention on exactly the kind of inbound-language and international-reputation work this series keeps asking Japanese operators to extend toward India — it's just extending it toward Chinese-speaking markets and a handful of Southeast Asian ones, with Singapore, Thailand, and Vietnam still the names on its own corporate materials. Hindi, and South Asia generally, remain off both the app's language list and the company's stated expansion targets.

Everything Else, Exactly Where Part 7 Left It

The remaining threads haven't moved. Neither the AYUSH Ministry nor the Health Ministry has confirmed that Jewar, or any other site, is one of the Union Budget's five regional medical-tourism hubs — that link still exists only in UP's own framing. AMED's own international-collaboration announcements for 2026 don't show a funded project under the May memorandum of cooperation with ICMR. Shiseido's reported interest in Indian manufacturing hasn't produced a site, an investment figure, or even a confirmed first move toward contract manufacturing; the most recent trade coverage this search could find still dates to mid-2026 and repeats the same unconfirmed evaluation Part 7 already reported. And on the exhibition circuit, FICCI's Advantage Healthcare India has already moved into its own next chapter — the 8th edition ran February 23–25, 2026, in Greater Noida, with Fortis Healthcare among the winners of its Medical Value Travel Awards — but no 9th edition has been dated yet, and the Services Export Promotion Council's SANJEEVANI, last held September 7–9, 2026, at Bharat Mandapam, has no announced successor either.

What's Still Missing

  • Official confirmation that Jewar — or any site — is one of the Union Budget's five regional medical-tourism hubs. UP's own announcements make the link; neither the AYUSH Ministry nor the Health Ministry has.
  • A ruling on YEIDA's requested one-year extension for the Medical Device Park, and a named Japanese tenant among its allottees — even as GE Healthcare, Philips, and Panacea now circle the same plots Medical Excellence Japan's framework agreement was supposed to fill first.
  • Clarity on whether Japan's JESTA-linked insurance study, now tied to a fiscal 2028 system and possibly a 2027 start, would actually govern the Indian medical travelers this series' hubs hope to send toward Japan — or whether India's separate visa process keeps that question open indefinitely.
  • A confirmed site, investment figure, or manufacturing partner for Shiseido's reported Indian production plan, more than a year after it first surfaced.
  • Dates for Advantage Healthcare India's ninth edition or SANJEEVANI's next edition, and a Japanese beauty or hospital operator whose language investment — like SBC Medical's growing Chinese-language program — finally reaches Hindi or South Asia rather than stopping there.

If you work in medtech investment, industrial site selection, cross-border healthcare policy, or language services for aesthetic and wellness clinics — get in touch. Closing the gap between what gets announced and what actually gets built is exactly the kind of work India Japan Kaizen exists to do.

This is Part 8 of India Japan Kaizen's Health & Beauty Bridge Series, publishing weekly. Part 9 will check whether the Centre has ruled on YEIDA's extension request, whether GE Healthcare's, Philips's, or Panacea's interest in the Medical Device Park has turned into a signed allotment, and whether Japan's JESTA-linked insurance study has hardened into an actual rule — and, if so, who it would apply to.

More from this series

View more →
🏭

November 8, 2026

Noida's Medical Device Park Misses Its Own Deadline

YEIDA's device park has slipped its completion deadline, Japan is tightening entry rules for the patients it's courting, and Shiseido quietly eyes Indian manufacturing. Part 7.

Read more →
📍

November 1, 2026

An Address Surfaces for India's Medical-Tourism Hub

YEIDA quietly gave the Budget's health hub an address in August — before Part 5 even looked. The device park, research pact, and beauty side's Hindi gap still haven't moved. Part 6.

Read more →
🏗️

October 25, 2026

Where India-Japan Health Ties Are Actually Moving

Part 4's two tracked questions are still open, but a Japanese medtech MoU, a Budget hub blueprint, and a beauty clinic's language rollout show where this relationship is actually moving. Part 5.

Read more →
🛡️

October 18, 2026

A New Health Pact, But the Insurance Gap Stays

India and Japan signed a health-research pact and Galaxy Health launched travel cover — but the inbound medical-tourism insurance product Goyal asked for in September still doesn't exist. Part 4.

Read more →
🌿

October 4, 2026

India Wants 10 Million Medical Tourists. Where's Japan?

India just set a 10-million-patient medical-tourism target while Japan's own inbound numbers stay tiny. Who's actually building the bridge, and the real state of Kampo-Ayurveda. Part 3.

Read more →
💉

September 27, 2026

A Vaccine, a Caregiver Visa, and Bioré's India Debut

A Japanese vaccine maker is transferring tech to Serum Institute, Kao picked its India partner for Bioré, and a caregiver pipeline has a mandate. Part 2 of our Health & Beauty Bridge Series.

Read more →
🧴

September 20, 2026

Pharma, Med-Tech, J-Beauty, and Ayurveda: India-Japan's Wellness Bridge

India's pharma exports to Japan are barely a rounding error, even as Japanese med-tech giants build factories across India. Meanwhile J-beauty is entering India and Ayurveda is entering Japan, at the same time. Part 1 of our weekly Health & Beauty Bridge Series.

Read more →

Explore other weekly series